In a recent interview on Stockhead TV’s Long Shortz, about Optiscan’s recent regulatory submission for its InSpecta device, a real-time microscopic imaging tool designed for veterinary use.

Dr Camile Farah explains how InSpecta enables vets to assess cancer margins during surgery and perform digital pathology directly in clinics, potentially transforming animal healthcare workflows.

The FDA submission marks a key milestone after two years of development, testing, and validation, and also lays the groundwork for future regulatory pathways across Optiscan’s human medical device portfolio.

Watch the full video here.